Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-01-02 @ 5:59 AM
Study NCT ID:
NCT04566458
Status:
COMPLETED
Last Update Posted:
2021-10-07
First Post:
2020-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RWD Study in HER2+ mBC Patients in Third-Line Therapy
Sponsor:
Exactis Innovation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Exactis-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |